שווי מצרפי של נכסים: Catheter Precision Inc (VTAK)

Catheter Precision (VTAK) is expanding its presence in the cardiology segment by implementing Amigo robotic systems to automate arrhythmia treatment within the B2B sector. Innovative VIVO systems provide surgeons with high-precision pathology localization, becoming a critical component of preoperative analysis. This market valuation chart reflects total assets at 32.69. Full support from the FDA and insurance companies guarantees rapid growth in procedure volume with zero customer churn.

Total assets define the scale of the company's property base, while an analysis of balance sheet assets allows for tracking the dynamics of total capital and liabilities, reverse-calculated via ROA to identify the actual development vector. This metric reflects the investments made by Catheter Precision (VTAK) into a high-tech cardiology infrastructure and the retention of elite biomedical personnel, which is critical for achieving its life-saving mission.